Haemonetics Corporation
DE ˙ DB ˙ US4050241003
€ 59,00 ↑3.00 (5.36%)
2026-06-04
PREÇO DA AÇÃO
SecurityDE:HAZ / Haemonetics Corporation
InstitutionCitigroup Inc
Latest Disclosed Ownership251,922 shares
Latest Disclosed Value $ 14,198,324
Citigroup Inc ownership in HAZ / Haemonetics Corporation

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 251,922 shares of Haemonetics Corporation (DE:HAZ) valued at $12,092,256 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 569,173 shares of Haemonetics Corporation. This represents a change in shares of -55.74% during the quarter. The current value of the position is $14,863,398 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (HAZ) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:HAZ / Haemonetics Corporation Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F HAEMONETICS CORP MASS COM 405024100 251,922 -317,251 -55.74 14,198 -68.88 0.0030
2026-02-13 2025-12-31 13F HAEMONETICS CORP MASS COM 405024100 569,173 140,132 32.66 45,619 118.16 0.0201
2025-11-10 2025-09-30 13F HAEMONETICS CORP MASS COM 405024100 429,041 -6,576 -1.51 20,911 -35.66 0.0093
2025-08-11 2025-06-30 13F HAEMONETICS CORP MASS COM 405024100 435,617 -189,948 -30.36 32,501 -18.24 0.0160
2025-05-12 2025-03-31 13F HAEMONETICS CORP MASS COM 405024100 625,565 291,574 87.30 39,755 52.44 0.0203
2025-02-12 2024-12-31 13F HAEMONETICS CORP MASS COM 405024100 333,991 140,333 72.46 26,078 67.53 0.0155
2024-11-12 2024-09-30 13F HAEMONETICS CORP MASS COM 405024100 193,658 -36,717 -15.94 15,566 -18.32 0.0090
2024-08-12 2024-06-30 13F HAEMONETICS CORP MASS COM 405024100 230,375 152,935 197.49 19,059 188.36 0.0122
2024-05-10 2024-03-31 13F HAEMONETICS CORP MASS COM 405024100 77,440 -72,759 -48.44 6,610 -48.54 0.0043
2024-02-09 2023-12-31 13F HAEMONETICS CORP MASS COM 405024100 150,199 -1,029 -0.68 12,844 -5.20 0.0090
2023-12-06 2023-09-30 13F/A-1 HAEMONETICS CORP MASS COM 405024100 151,228 -27,390 -15.33 13,547 -10.92 0.0101
2023-11-09 2023-09-30 13F HAEMONETICS CORP MASS COM 405024100 151,228 -27,390 13,547 0.0040
2023-08-10 2023-06-30 13F HAEMONETICS CORP MASS COM 405024100 178,618 74,190 71.04 15,208 75.99 0.0100
2023-05-11 2023-03-31 13F HAEMONETICS CORP MASS COM 405024100 104,428 -41,268 -28.32 8,641 -24.59 0.0061
2023-02-09 2022-12-31 13F HAEMONETICS CORP MASS COM 405024100 145,696 48,101 49.29 11,459 58.57 0.0091
2022-11-10 2022-09-30 13F HAEMONETICS CORP MASS COM 405024100 97,595 -36,131 -27.02 7,226 -17.10 0.0052
2022-08-10 2022-06-30 13F HAEMONETICS CORP MASS COM 405024100 133,726 14,624 12.28 8,717 15.78 0.0065
2022-05-12 2022-03-31 13F HAEMONETICS CORP MASS COM 405024100 119,102 7,271 6.50 7,529 26.92 0.0046
2022-02-10 2021-12-31 13F HAEMONETICS CORP MASS COM 405024100 111,831 -2,039 -1.79 5,932 -26.20 0.0032
2021-11-10 2021-09-30 13F HAEMONETICS CORP MASS COM 405024100 113,870 3,656 3.32 8,038 9.43 0.0047
2021-08-10 2021-06-30 13F HAEMONETICS CORP MASS COM 405024100 110,214 55,076 99.89 7,345 20.00 0.0044
2021-05-13 2021-03-31 13F HAEMONETICS CORP MASS COM 405024100 55,138 43,299 365.73 6,121 335.35 0.0040
2021-02-11 2020-12-31 13F HAEMONETICS COM 405024100 11,839 1,130 10.55 1,406 50.54 0.0008
2020-11-12 2020-09-30 13F HAEMONETICS COM 405024100 10,709 -15,548 -59.21 934 -60.29 0.0006
2020-08-12 2020-06-30 13F HAEMONETICS COM 405024100 26,257 -2,239 -7.86 2,352 -17.21 0.0018
2020-05-12 2020-03-31 13F HAEMONETICS COM 405024100 28,496 4,355 18.04 2,841 2.42 0.0026
2020-02-12 2019-12-31 13F HAEMONETICS COM 405024100 24,141 20,122 500.67 2,774 447.14 0.0020
2019-11-08 2019-09-30 13F HAEMONETICS COM 405024100 4,019 -122 -2.95 507 1.81 0.0004
2019-08-12 2019-06-30 13F HAEMONETICS COM 405024100 4,141 -25,684 -86.12 498 -80.90 0.0004
2019-05-13 2019-03-31 13F HAEMONETICS COM 405024100 29,825 4,827 19.31 2,608 4.28 0.0025
2019-02-12 2018-12-31 13F HAEMONETICS COM 405024100 24,998 21,346 584.50 2,501 496.90 0.0025
2018-11-13 2018-09-30 13F HAEMONETICS COM 405024100 3,652 1,581 76.34 419 125.27 0.0004
2018-08-10 2018-06-30 13F HAEMONETICS COM 405024100 2,071 -14,572 -87.56 186 -84.73 0.0002
2018-05-11 2018-03-31 13F HAEMONETICS COM 405024100 16,643 -15,230 -47.78 1,218 -34.20 0.0010
2018-02-12 2017-12-31 13F HAEMONETICS COM 405024100 31,873 -14,151 -30.75 1,851 -10.36 0.0015
2017-11-13 2017-09-30 13F HAEMONETICS COM 405024100 46,024 -9,347 -16.88 2,065 -5.54 0.0017
2017-08-11 2017-06-30 13F HAEMONETICS COM 405024100 55,371 2,242 4.22 2,186 1.44 0.0020
2017-05-12 2017-03-31 13F HAEMONETICS COM 405024100 53,129 -45,752 -46.27 2,155 -45.79 0.0019
2017-02-10 2016-12-31 13F HAEMONETICS COM 405024100 98,881 61,546 164.85 3,975 194.01 0.0036
2016-11-10 2016-09-30 13F HAEMONETICS COM 405024100 37,335 13,001 53.43 1,352 91.50 0.0013
2016-08-12 2016-06-30 13F HAEMONETICS COM 405024100 24,334 -14,381 -37.15 706 -47.82 0.0007
2016-05-13 2016-03-31 13F HAEMONETICS COM 405024100 38,715 36,010 1,331.24 1,353 1,473.26 0.0015
2016-02-12 2015-12-31 13F HAEMONETICS COM 405024100 2,705 -905 -25.07 86 -25.86 0.0001
2015-11-13 2015-09-30 13F HAEMONETICS COM 405024100 3,610 -324 -8.24 116 -28.83 0.0001
2015-08-13 2015-06-30 13F HAEMONETICS COM 405024100 3,934 -1,075 -21.46 163 -27.56 0.0001
2015-05-14 2015-03-31 13F HAEMONETICS COM 405024100 5,009 1,761 54.22 225 85.95 0.0002
2015-02-17 2014-12-31 13F HAEMONETICS COM 405024100 3,248 -1,816 -35.86 121 -31.64 0.0001
2014-11-14 2014-09-30 13F HAEMONETICS COM 405024100 5,064 328 6.93 177 5.99 0.0002
2014-08-14 2014-06-30 13F HAEMONETICS COM 405024100 4,736 1,882 65.94 167 79.57 0.0002
2014-05-15 2014-03-31 13F HAEMONETICS COM 405024100 2,854 -17,388 -85.90 93 -89.08 0.0001
2014-02-14 2013-12-31 13F HAEMONETICS COM 405024100 20,242 -8,288 -29.05 852 -25.13 0.0008
2013-11-14 2013-09-30 13F HAEMONETICS COM 405024100 28,530 -3,288 -10.33 1,138 -13.53 0.0011
2013-08-14 2013-06-30 13F HAEMONETICS COM 405024100 31,818 31,818 1,316 0.0013
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F HAEMONETICS CORP MASS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-13 2025-12-31 13F HAEMONETICS CORP MASS COM Call 220,000 17,633 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.